Patient Application Form

Illustration of the prevalence of Chronic rhinosinusitis with and without polyps in the
general population

If you have chronic rhinosinusitis with nasal polyp or allergies and would like to support our research, our highly skilled team is looking forward to talking to you!

Ongoing studies:

EpiBar: Treatment with the licensed drug dupilumab (Dupixent) for treatment of nasal polyps to investigate the role on epithelial barrier function, nasal sampling at baseline and after 3 and 6 months.

Upcoming studies:

  • Mozart: National observational study to investigate the efficacy of the licensed drug mepolizumab (Nucala) for the treatment of nasal polyps.

  • Response: International observational study to investigate the efficacy of the licensed drug mepolizumab (Nucala) for the treatment of nasal polyps.

  • Allergy & Age: Study to investigate immune response to allergen provocation in patients with current or former respiratory allergy aged 60+We are happy to provide you with further information on our studies.

Fill the application form
Thank you!

Your submission has been received!
Oops! Something went wrong while submitting the form.